Status:
COMPLETED
Effects of Curcumin Supplementation in Patients With Chronic Kidney Disease on Peritoneal Dialysis
Lead Sponsor:
Universidade Federal Fluminense
Conditions:
Chronic Kidney Diseases
Peritoneal Dialysis
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The objective of this study is to assess whether supplementation with curcumin could modulate the intestinal microbiota, reducing levels of inflammatory markers of oxidative stress, uremic toxins and ...
Detailed Description
Curcumin is a chemical compound of the curcuminoids class found in the root of Curcuma (Curcuma longa), and due to its potential antioxidant and anti-inflammatory, has been suggested as a nutritional ...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Chronic Kidney Disease
- Peritoneal dialysis patients for more than 6 months
- Aged from 18 to 60 years
- Must be able to swallow tablets
Exclusion
- Patients pregnant
- Smokers
- Using antibiotics in the last 3 months
- Using antioxidant supplements in the last 3 months
- Usual intake of turmeric
- Usual intake Autoimmune
- Clinical diagnosis of infectious diseases
- Clinical diagnosis of Cancer
- Clinical diagnosis of AIDS
Key Trial Info
Start Date :
October 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 5 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04413266
Start Date
October 10 2020
End Date
October 5 2023
Last Update
December 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Denise Mafra
Rio de Janeiro, Rio de Janeiro, Brazil, 22260050